Meihua International Medical Technologies
MHUA
MHUA was delisted on the 8th of December, 2025.
9 hedge funds and large institutions have $118K invested in Meihua International Medical Technologies in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
35% more capital invested
Capital invested by funds: $87.7K → $118K (+$30.3K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$49.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7.92K |
| 3 |
Renaissance Technologies
New York
|
+$4.09K |
| 4 |
MG
Marex Group
London,
|
+$3.96K |
| 5 |
Jane Street
New York
|
+$429 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$14K |
| 2 |
HF
HRT Financial
New York
|
-$11K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$5.24K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$4K |
| 5 |
Two Sigma Investments
New York
|
-$857 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $50.5K | +$49.6K | +1,505 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $28.9K | +$7.92K | +240 | +39% |
|
|
3
Two Sigma Investments
New York
| $9.34K | -$857 | -26 | -9% |
|
|
4
Jane Street
New York
| $8.89K | +$429 | +13 | +5% |
|
|
XT
5
XTX Topco
George Town,
Cayman Islands
| $6.37K | -$5.24K | -159 | -46% |
|
6
Geode Capital Management
Boston,
Massachusetts
| $4.83K | – | – | – |
|
|
7
Renaissance Technologies
New York
| $4.16K | +$4.09K | +124 | New |
|
|
MG
8
Marex Group
London,
| $4.03K | +$3.96K | +120 | New |
|
9
Morgan Stanley
New York
| $934 | – | – | – |
|
|
VF
10
Virtu Financial
New York
| – | -$14K | -414 | Closed |
|
|
HF
11
HRT Financial
New York
| – | -$11K | -334 | Closed |
|
|
TSS
12
Two Sigma Securities
New York
| – | -$4K | -116 | Closed |
|
MHUA Hedge Fund Activity: Q1 2025 in Review
9 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Meihua International Medical Technologies (MHUA) for Q1 2025, worth a combined $118K — up 35% from $87.7K a quarter earlier.
Fund positioning in MHUA was balanced in Q1 2025: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $49.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $14K sold.
- 9 institutional investors held Meihua International Medical Technologies (MHUA) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $118K of Meihua International Medical Technologies stock for Q1 2025, up 35% quarter-over-quarter.
- 3 funds opened new Meihua International Medical Technologies positions in Q1 2025 and 3 closed out, a net change of 0 holders.
- The largest Meihua International Medical Technologies buyer in Q1 2025 was Citadel Advisors, an estimated $49.6K added.
- The largest Meihua International Medical Technologies seller in Q1 2025 was Virtu Financial, an estimated $14K sold.
Based on aggregated 13F filings for Q1 2025.